stars 1 stars 2 stars 3

QUANTITATIVE, EVIDENCE-BASED DIAGNOSTIC TESTING PROTOCOL EMPOWERING YOU TO: Objectively VALIDATE subjective pain scores. Yes! Based on 3-4 cardiac bio-markers, you can affirm that a patient is truly in Pain. QUANTIFY the effectiveness of any treatment algorithm---including weight loss, smoking cessation, maintenance medications, interventional pain therapies, physical therapy, medication management, etc. A patient’s cardiac bio-markers will improve as their overall health improves and pain decreases. MEASURE Physical and Mental Stress and the impact of pain EVALUATE compliance in treatment plans. ESTABLISH proper expectations for healing. IDENTIFY early on-set risk factors for cardiovascular disease, especially for t those patients that are experiencing other co-morbidities in addition to chronic pain. EXPOSE developing or advancing neuropathies, arterial stiffness, inflammation, etc ……critical in pre/post-op, or procedural protocols. MITIGATE risk and elevate MIPS/MACRA score ADD $35-50K/month in NET incremental revenue We look forward to learning more about your practice and sharing more of the VSD message. Message us to learn more and to get your confidential practice evaluation.

VS Diagnostics Questions

The VS Diagnostics annual revenue was $5 million in 2026.

Amber Hamby is the Executive Vice President of Operations of VS Diagnostics.

2 people are employed at VS Diagnostics.

VS Diagnostics is based in Cheyenne, Wyoming.

The NAICS codes for VS Diagnostics are [621, 62151, 62, 6215].

The SIC codes for VS Diagnostics are [80, 807].

Top VS Diagnostics Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users